Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients
- 7 April 1983
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 308 (14) , 800-805
- https://doi.org/10.1056/nejm198304073081402
Abstract
We studied the ability of a single oral dose of aspirin to inhibit prostacyclin synthesis by human arterial and venous tissue and to inhibit thromboxane A2 synthesis by platelets in 70 patients who were undergoing aortocoronary bypass. A dose of 40, 80, or 325 mg of aspirin was administered 12 to 16 hours before surgery.This publication has 27 references indexed in Scilit:
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENTThe Lancet, 1981
- Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirinThe American Journal of Cardiology, 1981
- DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESISThe Lancet, 1981
- CUMULATIVE INHIBITORY EFFECT OF DAILY 40 mg ASPIRIN ON PROSTACYCLIN SYNTHESISThe Lancet, 1981
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRINThe Lancet, 1979
- Failure of Antiplatelet and Anticoagulant Therapy to Improve Patency of Grafts after Coronary-Artery BypassNew England Journal of Medicine, 1979
- Thrombogenic Effect of High-Dose Aspirin in RabbitsJournal of Clinical Investigation, 1978